Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal)

  • Technology appraisal
  • TA286
  • Published: 

History

Background information

Schizophrenia or bipolar disorder - loxapine: equality impact assessment - scoping

Schizophrenia or bipolar disorder - loxapine: appendix D - response to comments on the draft scope

Schizophrenia or bipolar disorder - loxapine: appendix C - final matrix

Schizophrenia or bipolar disorder - loxapine: appendix B - final scope

Schizophrenia or bipolar disorder - loxapine: appendix B - draft scope for consultation (pre-referral) March 2011

Schizophrenia or bipolar disorder - loxapine: appendix C - provisional matrix (pre-referral) March 2011